Coaxial bioprinting of microsphere bioink to engineer heterogeneous vascularized lung cancer model
Biomaterials Advances · 2026
DOI: 10.1016/j.bioadv.2026.214741 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomaterials Advances, 2026. Verfasst von Qiulei Gao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Henan Province Engineering Technology Research Center of MEMS Manufacturing and Applications, School of Mechanics and Safety Engineering, Zhengzhou U…. Hauptthemen laut MEDLINE: Bioprinting, Microspheres, Lung Neoplasms, Neovascularization, Pathologic. Die Arbeit nennt 51 Literaturangaben. Gefördert von: Key Research and Development Program of Hunan Province of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
3D bioprinting is a promising strategy for engineering in vitro tumor models. However, replicating the intratumoral parenchyma-stroma heterogeneity remains challenging due to the poor formability of biomimetic bioinks. In this study, we developed a method to enable the direct extrusion of low-concentration gelatin-methacrylate (GelMA)/Matrigel by overcoming its rheological limitations. The bioink was then incorporated within a coaxial bioprinting system to engineer a defined tumor parenchyma-stroma interface. The coaxial lung cancer model featured a dual-layer tubular structure. In this structure, the inner microsphere bioink was designed to mimic the tumor parenchyma, and the surrounding HAMA/Fibrin hydrogel was used to reproduce the stroma. The model not only established the spatial heterogeneity but also recapitulated biological function such as fibroblast-driven angiogenesis, as demonstrated by a 3.4-fold increase in microvascular density and a 2.3-fold extension in total vessel length. Furthermore, the model exhibited 50-fold increase in drug resistance compared to two-dimensional (2D) cultures. Additionally, the long-term cryopreservation stability and scalability endowed the model with the potential to be a tool for on-demand use. This work provides a potential platform for drug screening and mechanistic investigation of tumor biology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Henan Province Engineering Technology Research Center of MEMS Manufacturing and Applications, School of Mechanics and Safety Engineering, Zhengzhou University, Zhengzhou, 450001, China.
- Henan Province Engineering Technology Research Center of MEMS Manufacturing and Applications, School of Mechanics and Safety Engineering, Zhengzhou University, Zhengzhou, 450001, China. Electronic address: zwguo@zzu.edu…
- Department of Mechanical Engineering and Mechanics, Tsinghua University, Beijing, 100084, China.
- Henan Province Engineering Technology Research Center of MEMS Manufacturing and Applications, School of Mechanics and Safety Engineering, Zhengzhou University, Zhengzhou, 450001, China. Electronic address: qjjzzu@zzu.ed…
- Henan Province Engineering Technology Research Center of MEMS Manufacturing and Applications, School of Mechanics and Safety Engineering, Zhengzhou University, Zhengzhou, 450001, China; Industrial Technology Research In…
Förderung
- Key Research and Development Program of Hunan Province of China
- National Natural Science Foundation of China
Zitieren
APA
Gao, Q., Guo, Z., Zhang, S., Xia, J., Li, J., Yuan, T., Chen, J., Fang, Y., Qiu, J., & Wei, R. (2026). Coaxial bioprinting of microsphere bioink to engineer heterogeneous vascularized lung cancer model. Biomaterials Advances. https://doi.org/10.1016/j.bioadv.2026.214741
Vancouver
Gao Q, Guo Z, Zhang S, Xia J, Li J, Yuan T, et al. Coaxial bioprinting of microsphere bioink to engineer heterogeneous vascularized lung cancer model. Biomaterials Advances. 2026. doi:10.1016/j.bioadv.2026.214741
BibTeX
@article{Gao2026,
author = {Gao, Qiulei and Guo, Zhongwei and Zhang, Shiqiang and Xia, Jingjing and Li, Junfu and Yuan, Tianying and Chen, Jiyu and Fang, Yongcong and Qiu, Jingjiang and Wei, Ronghan},
title = {Coaxial bioprinting of microsphere bioink to engineer heterogeneous vascularized lung cancer model},
journal = {Biomaterials Advances},
year = {2026},
doi = {10.1016/j.bioadv.2026.214741}
}
EUVIMED